HUTCHMED (China) Limited American Depositary Shares HCM

$14.12 +0.07% at last close

Analyst Consensus

Consensus Rating
Hold (1 Buy · 1 Hold · 1 Sell)
Average Price Target
$14.92
Implied Upside
+5.6%
Price Target Range
$13.75 – $17.00
Analysts (12 mo)
3

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-07-23
Goldman SachsPaul Choi
Maintains Neutral $16 → $14
2026-07-07
B of A SecuritiesAlec Stranahan
Maintains Buy $20 → $17
2026-03-10
B of A SecuritiesDimple Gosai
Maintains Buy $21 → $20
2025-09-22
Morgan StanleyJack Lin
Downgrades Equal-weight → Underweight $18 → $14
2025-07-22
B of A SecuritiesDimple Gosai
Maintains Buy $27 → $28
2024-08-01
Goldman SachsPaul Choi
Maintains Neutral $17 → $19
2023-11-24
Deutsche BankCyrus Ng
Upgrades Hold → Buy $20 → $22
2023-11-10
Goldman SachsPaul Choi
Maintains Neutral $15 → $17
2023-09-05
Cantor FitzgeraldLouise Chen
Reiterates Overweight $50
2023-07-24
Cantor FitzgeraldLouise Chen
Reiterates Overweight $50
2022-08-09
Goldman SachsPaul Choi
Maintains Neutral $14 → $16
2022-08-02
Goldman SachsPaul Choi
Maintains Neutral $16 → $14
2021-09-22
Goldman SachsPaul Choi
Downgrades Buy → Neutral $46
2021-08-03
JefferiesKelly Shi
Initiates coverage on Buy $52
2020-03-13
Cantor FitzgeraldLouise Chen
Initiates coverage on Overweight
2020-02-20
Goldman SachsPaul Choi
Initiates coverage on Buy $38
2019-11-19
CLSA
Initiates coverage on Buy
2019-10-23
B of A Securities
Reinstates Buy
2019-03-04
Deutsche Bank
Initiates coverage on Buy
2017-10-17
Canaccord GenuityJohn Newman
Maintains Buy $30 → $38
2016-04-11
Stifel
Initiates coverage on Buy
2016-04-11
Canaccord GenuityJohn Newman
Initiates coverage on Buy $20
2016-04-11
B of A Securities
Initiates coverage on Buy

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$14.12
Market Cap
$2.45 billion
52-Week Range
$9.77 $18.30
Average Volume
76K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.